ATCO and DKSH Expand Their Strategic Collaboration for the Commercialization of Healthcare Products in the Philippines

DKSH expands its collaboration with ATCO in the Philippines to provide a range of high-quality pharmaceutical products for hospitals, clinics, and pharmacies across the country.

Manila, January 11, 2022 — DKSH Business Unit Healthcare, Asia’s leading partner for healthcare companies seeking to grow their business in Asia and beyond, and ATCO, one of the largest pharmaceutical companies in Pakistan, have expanded their partnership in Asia to bring a wide range of affordable and high-quality pharmaceutical products to patients, pharmacies, hospitals, and clinics in the Philippines.

ATCO and DKSH have been partnering in Singapore, Malaysia, Vietnam, and Myanmar since January 2021. ATCO is a leading pharmaceutical company which develops, formulates, and produces high- quality branded pharmaceutical generics and nutraceuticals. ATCO manufactures products across a range of therapeutic categories, including dermatology, cardiology, diabetes, ophthalmology, and pediatrics, among others. In this expanded partnership to the Philippines, DKSH will drive growth for ATCO’s healthcare products in its portfolio, such as Adapco (treatment for acne), Betasalic (treatment for chronic skin inflammatory dermatoses), Micronema (treatment to relieve constipation), and Zincat OD (WHO-recommended formulation for the management of diarrhea). DKSH will provide ATCO with full-agency services, including importation, marketing and sales, as well as logistics and distribution.

Saeed Allawala, Chairman of ATCO Laboratories Limited, said: “We are excited to expand our partnership with DKSH. This strategic collaboration will enable us to continue our efforts to provide patients with access to affordable and high-quality pharmaceutical products and improve their lives. We have partnered with DKSH in Singapore, Malaysia, Vietnam, Myanmar, and now the Philippines — we trust DKSH’s capabilities to expand our growth and strengthen the commercial footprint in Asia.”

Bijay Singh, Global Head of Business Unit Healthcare, DKSH, added: “Our mission is to provide quality products to patients in Asia and enrich their lives. With our extensive distribution network in pharmacies, hospitals, and clinics across the region, and our strong capabilities in marketing, sales, and logistics, we are proud to be the trusted partner for ATCO. We are confident to improve access to ATCO’s wide range of products for patients in the Philippines.”


About ATCO

ATCO Laboratories Limited is one of the pioneers in Pakistan’s pharmaceutical industry sector, and has been serving the country’s healthcare system over the last four decades. ATCO develops, formulates and markets high quality generics at its state-of-the-art cGMP compliant manufacturing facility based in Karachi, which is the industrial hub of Pakistan. ATCO is cGMP certified from Drug Authority of Pakistan (DRAP) and holds other accreditations from various health authorities of the world.